TerminatedNot Applicable

Cancer Parenting Program for the Enhancement of the Quality of Life of Patients With Advanced Cancer and Their Children

Stopped: Enrollment rates to the trial were lower than projected and anticipated.

United States174 participantsStarted 2022-07-19

Plain-language summary

This trial examines the usefulness of two educational programs for parents with late-stage cancer who have a 5 - 17 year old child. The programs are designed to enhance the quality of the parent-child relationship and add to the parent's confidence in managing the impact of their cancer on their child. Educational programs may reduce anxiety and depression and improve the well-being and quality of life of parents with advanced cancers and their children. Recruitment occurs nationally via referral to the Fred Hutch/University of Washington Cancer Consortium team.

Who can participate

Age range

23 Years – 68 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Parents with any type of late-stage, non-curable cancer (determined by TNM stage IV cancer for solid tumors or 2 or more cycles of treatment failure with disease relapse in non-solid tumors) * All therapies are allowable * 23 years (yr.) to 68 yr. Age restriction exists for the patient based on parent having a child ages 5-17 * Patient must have a child (5yr. -17 yr.) living in the home at least 50% of the time and residential with non-ill parent or parent surrogate * Read and write English as one of their languages of choice * Have access to a telephone * Ability to understand and the willingness to sign a written informed consent document. Read and write English as one of their languages of choice Exclusion Criteria: * Patient is in hospice at time of enrollment * Non-ill co-parent does not consent to join study

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Treatment efficacy assessed by parents' mood (CES-D)

Timeframe: At 3 months post-baseline

Treatment efficacy assessed by parents' anxiety [Spielberger State-Trait Anxiety (STAI, state scale)]

Timeframe: At 3 months post-baseline

Parent's confidence in being able to talk with her child about the child's cancer-related concerns (CASE Help Child Subscale)

Timeframe: At 3 months post-baseline

Parents' skills in helping their child cope and manage the toll of the parents' cancer (Connecting and Coping Subscale)

Timeframe: At 3 months post-baseline

Child-Behavioral Emotional Functioning: Anxious/Depressed, Internalizing, Externalizing scores on CBCL

Timeframe: At 3 months post-baseline

Trial details

NCT IDNCT05477784

SponsorUniversity of Washington

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-05-21

View on ClinicalTrials.gov More Parenting trials

Plain-language summary

Who can participate

Age range

23 Years – 68 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Treatment efficacy assessed by parents' mood (CES-D)

Timeframe: At 3 months post-baseline

Treatment efficacy assessed by parents' anxiety [Spielberger State-Trait Anxiety (STAI, state scale)]

Timeframe: At 3 months post-baseline

Parent's confidence in being able to talk with her child about the child's cancer-related concerns (CASE Help Child Subscale)

Timeframe: At 3 months post-baseline

Parents' skills in helping their child cope and manage the toll of the parents' cancer (Connecting and Coping Subscale)

Timeframe: At 3 months post-baseline

Child-Behavioral Emotional Functioning: Anxious/Depressed, Internalizing, Externalizing scores on CBCL

Timeframe: At 3 months post-baseline